Switzerland

The US private equity investor SK Capital LP has acquired the Swixx BioPharma Group. The Swixx BioPharma Group is a leading global full-service partner in the distribution of biopharmaceutical products, particularly in Central and Eastern Europe and Latin America. Bär & Karrer is acting as counsel to SK Capital LP in this transaction. The team is led by Christoph Neeracher and Philippe Seiler and also includes Therry Lehmann, Thomas Rohde, Romina Lauper, Rahel Brüschweiler, Markus Mezger, Max Winnenburg (all M&A), Susanne Schreiber, Martin Leu, and Leotrim Berisha (Tax), Markus Wang and Christine Schweikard (IP/IT), Mani Reinert, Li Wei Dutler, and Martin Werner (Competition), Christian Kunz and Katharina Cardon (Data Protection), Markus Schott, Julia Stempfel, and Jan Grossniklaus (Regulatory), Rocco Rigozzi and Patrick Neher (Real Estate), Laura Widmer and Manuel Schmid (Employment), Ralph Malacrida and Colin Giezendanner (Financing), and Mariel Hoch (Public M&A). For further information please contact: Media Relations, Eric Stupp Tel: +41 58 261 50 00 Email: [email protected]

The Tertianum Group is acquiring Senevita AG. This transaction will see two longstanding Swiss providers in the field of residential care and nursing for the elderly join forces. The Swiss Competition Commission (COMCO) has approved the transaction, which is scheduled to be completed in the first quarter of 2026. Bär & Karrer acts as legal advisor to Tertianum in this transaction. The team was led by Dr. Christoph Neeracher and Dr. Philippe Seiler and consisted of Ronny Schmid, Yascha Fengler, Dr. Luca Jagmetti, Björn Wegberg, Markus G. Mezger, and Leo Schall (all M&A), Susanne Schreiber, Martin Leu, Cyrill Diefenbacher, and Aron Liechti (all Tax), Corrado Rampini, Patrick Neher, Fanny Cattaneo, and Hannah Birchmeier (all Real Estate), Mani Reinert, Martin P. Werner, Li Wei Dutler, and Pietro Calcagni (all Antitrust), Laura Widmer and Luljeta Morina (both Employment), Markus Wang and Christine Schweikard (both IP/IT), Ruth BlochRiemer and Sébastien Di Natale (both Pensions), as well as Lukas Roesler (Financing). For further information please contact: Media Relations, Eric Stupp Tel: +41 58 261 50 00 Email: [email protected]

On 14 August 2025 Tecan Group Ltd. (SIX Swiss Exchange: TECN) successfully issued CHF 150 million 0.85% fixed rate domestic straight bonds due 2030. The bonds are listed and traded on the SIX Swiss Exchange. UBS Investment Bank and Zürcher Kantonalbank acted as joint lead managers, with Bank J. Safra Sarasin serving as co-lead manager. Bär & Karrer acted as legal advisor to Tecan. The team included Lukas Roesler, Ralph Malacrida and Selin Ickin (all Capital Markets and Corporate), as well as Susanne Schreiber and Lesia Tüchthuisen (both Tax).

L’Oréal, the world leader in beauty, acquires an additional 10% stake in Galderma Group AG (Galderma), the pure-play dermatology category leader and one of the world’s largest players in injectable aesthetics, from Sunshine SwissCo AG, Abu Dhabi Investment Authority, and Auba Investment Pte. Ltd. (a consortium led by EQT).  This transaction increases L’Oréal’s strategic stake in Galderma to 20% of the share capital. The transaction will be implemented by way of an off-market block trade with the EQT-led consortium. L’Oréal and Galderma will also explore reinforcing their existing scientific partnership. Bär & Karrer is acting as Swiss legal counsel for L’Oréal. The team includes Mariel Hoch, Dieter Dubs, Fabienne Perlini-Frehner, Marlene Lienau, Dominic Leu, Nick Wälti and Ben Tschigg (all M&A) and Mani Reinert (Antitrust) For further information please contact: Media Relations, Eric Stupp Tel: +41 58 261 50 00 Email: [email protected]